J. B. Chemicals & Pharmaceuticals Limited Share Price
Equities
JBCHEPHARM
INE572A01036
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,896 INR | -0.54% | +6.31% | +16.72% |
Sales 2024 * | 35.01B 419M | Sales 2025 * | 40.58B 486M | Capitalization | 296B 3.54B |
---|---|---|---|---|---|
Net income 2024 * | 5.64B 67.54M | Net income 2025 * | 7.06B 84.57M | EV / Sales 2024 * | 8.49 x |
Net Debt 2024 * | 1.32B 15.79M | Net cash position 2025 * | 4.41B 52.86M | EV / Sales 2025 * | 7.18 x |
P/E ratio 2024 * |
49.5
x | P/E ratio 2025 * |
39.6
x | Employees | 5,095 |
Yield 2024 * |
0.64% | Yield 2025 * |
0.75% | Free-Float | 45.82% |
Latest transcript on J. B. Chemicals & Pharmaceuticals Limited
1 day | -0.54% | ||
1 week | +6.31% | ||
Current month | +14.95% | ||
1 month | +12.37% | ||
3 months | +14.82% | ||
6 months | +36.28% | ||
Current year | +16.72% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 05/20/05 | |
Bharat Dhanani
COO | Chief Operating Officer | - | - |
Sujay Rajhans
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 31/20/31 | |
Akshay Tanna
BRD | Director/Board Member | 40 | 07/11 |
Gaurav Trehan
BRD | Director/Board Member | 48 | 10/21/10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.43% | - | |
0.00% | 117 M€ | +1.54% | - |
Date | Price | Change | Volume |
---|---|---|---|
30/24/30 | 1,896 | -0.54% | 1 699 |
29/24/29 | 1,906 | +2.27% | 2,921 |
26/24/26 | 1,864 | +0.48% | 973 |
25/24/25 | 1,855 | +1.69% | 7,046 |
24/24/24 | 1,824 | +2.30% | 4,047 |
Delayed Quote Bombay S.E., April 30, 2024 at 12:40 pm IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.72% | 3.55B | |
+26.47% | 664B | |
+26.43% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.40% | 234B | |
+4.84% | 199B | |
-10.10% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- JBCHEPHARM Stock